Equity Profile

CON

Concentra Group Holdings Parent, Inc.

Health CareHealth Care Facilities$4.5B

Aug6Thu

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

Concentra Group Holdings Parent, Inc. operates in the health care sector, focusing on health care facilities....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of profitability, and investors will be looking for a positive trend to gauge the company's financial health.

N/A

Revenue Growth

Revenue growth is crucial for assessing the company's ability to expand its operations and market share in the competitive health care industry.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

CON Q2-2026 Earnings Preview

Context

Company Snapshot

Concentra Group Holdings Parent, Inc. operates in the health care sector, focusing on health care facilities. As a company with a market cap of $4 billion, it plays a significant role in providing essential health services, which are increasingly important in today's health-conscious environment.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+5.29%

Avg Stock Reaction

-0.23%

Last Quarter Recap

In Q1-2026, Concentra reported an EPS of $0.39, beating estimates by 11.43%. The stock reacted positively, gaining 3.42% the following day.

Management Promises & Guidance

Management emphasized their commitment to improving operational efficiency.
They highlighted plans to expand service offerings in key markets.
Management expressed confidence in maintaining strong patient satisfaction scores.

Expectations

Wall Street Expectations

Overall, expectations for Concentra's upcoming earnings are mixed, with no analyst estimates available. Investors are keen to see if the company can continue its trend of beating EPS estimates.

Bull Case

If Concentra can deliver strong EPS and show solid revenue growth, it may reinforce investor confidence and lead to a significant stock price increase.

Bear Case

Conversely, if the company fails to meet expectations or shows signs of slowing growth, it could lead to a negative reaction in the stock price.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q2-2026?

Given the company's strong track record of beating EPS estimates, this figure will be crucial for investor sentiment.

How is revenue growth trending compared to previous quarters?

Investors will closely watch revenue growth to assess the company's ability to expand and maintain its market position.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate Concentra's ability to maintain high patient satisfaction scores, which could drive revenue growth beyond expectations.

Supporting Evidence

The company has consistently beaten EPS estimates, indicating strong operational management.

Recent trends in patient satisfaction suggest potential for increased service utilization.

Options pricing indicates a significant move, reflecting heightened investor interest and potential for positive surprises.

Key Risk

If revenue growth exceeds expectations, it could challenge the current cautious sentiment in the market.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is critical as it will reveal whether Concentra can sustain its growth trajectory amidst industry challenges.

Bull Confirmed If

An EPS of $0.42 or higher would confirm the bull case and indicate strong operational performance.

Bear Confirmed If

An EPS below $0.35 would confirm the bear case, suggesting potential challenges in profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±10.87%

Historical Avg

±1.9%

Pricing rich

The options market is pricing in a significant potential move, suggesting that investors are anticipating volatility around the earnings report.

Options are pricing ±10.9% while CON has averaged ±1.9% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.4%

30d HV

24.7%

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Concentra beats expectations, history suggests the stock could rise by an average of 1.87% on the following day, confirming strong operational momentum.

In-Line / Cautious

If results are in line with expectations, the stock may experience a muted reaction as investors await further guidance from management.

Miss

A miss could lead to a decline of around 1.30%, reflecting investor disappointment and concerns about future growth.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on operational efficiency improvements.
2Details on expansion plans in key markets.
3Insights into patient satisfaction scores and their impact on revenue.
4Management's outlook on future growth and market conditions.
5Any commentary on competitive pressures in the health care sector.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Danaos Corporation

Company Snapshot

Concentra Group Holdings Parent, Inc. operates in the health care sector, focusing on health care facilities....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of profitability, and investors will be looking for a positive trend to gauge the company's financial health.

N/A

Revenue Growth

Revenue growth is crucial for assessing the company's ability to expand its operations and market share in the competitive health care industry.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

CON Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+5.29%

Avg Stock Reaction

-0.23%

Last Quarter Recap

In Q1-2026, Concentra reported an EPS of $0.39, beating estimates by 11.43%. The stock reacted positively, gaining 3.42% the following day.

Management Promises & Guidance

Management emphasized their commitment to improving operational efficiency.
They highlighted plans to expand service offerings in key markets.
Management expressed confidence in maintaining strong patient satisfaction scores.

Expectations

Wall Street Expectations

Overall, expectations for Concentra's upcoming earnings are mixed, with no analyst estimates available. Investors are keen to see if the company can continue its trend of beating EPS estimates.

Bull Case

If Concentra can deliver strong EPS and show solid revenue growth, it may reinforce investor confidence and lead to a significant stock price increase.

Bear Case

Conversely, if the company fails to meet expectations or shows signs of slowing growth, it could lead to a negative reaction in the stock price.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q2-2026?

Given the company's strong track record of beating EPS estimates, this figure will be crucial for investor sentiment.

How is revenue growth trending compared to previous quarters?

Investors will closely watch revenue growth to assess the company's ability to expand and maintain its market position.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate Concentra's ability to maintain high patient satisfaction scores, which could drive revenue growth beyond expectations.

Supporting Evidence

The company has consistently beaten EPS estimates, indicating strong operational management.

Recent trends in patient satisfaction suggest potential for increased service utilization.

Options pricing indicates a significant move, reflecting heightened investor interest and potential for positive surprises.

Key Risk

If revenue growth exceeds expectations, it could challenge the current cautious sentiment in the market.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is critical as it will reveal whether Concentra can sustain its growth trajectory amidst industry challenges.

Bull Confirmed If

An EPS of $0.42 or higher would confirm the bull case and indicate strong operational performance.

Bear Confirmed If

An EPS below $0.35 would confirm the bear case, suggesting potential challenges in profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±10.87%

Historical Avg

±1.9%

Pricing rich

The options market is pricing in a significant potential move, suggesting that investors are anticipating volatility around the earnings report.

Options are pricing ±10.9% while CON has averaged ±1.9% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.4%

30d HV

24.7%

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Concentra beats expectations, history suggests the stock could rise by an average of 1.87% on the following day, confirming strong operational momentum.

In-Line / Cautious

If results are in line with expectations, the stock may experience a muted reaction as investors await further guidance from management.

Miss

A miss could lead to a decline of around 1.30%, reflecting investor disappointment and concerns about future growth.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on operational efficiency improvements.
2Details on expansion plans in key markets.
3Insights into patient satisfaction scores and their impact on revenue.
4Management's outlook on future growth and market conditions.
5Any commentary on competitive pressures in the health care sector.